Clinical Trial Update: Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is currently recruiting to evaluate a combination of two approved drugs with one experimental drug in patients with relapsed or refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING